Literature DB >> 27736087

Antibacterial and Cytotoxic Actinomycins Y6-Y9 and Zp from Streptomyces sp. Strain Gö-GS12.

Wenlong Cai1, Xiachang Wang1, Sherif I Elshahawi1, Larissa V Ponomareva1, Xiaodong Liu1, Matthew R McErlean1, Zheng Cui1, Ashley L Arlinghaus1, Jon S Thorson1, Steven G Van Lanen1.   

Abstract

Four new Y-type actinomycin analogues named Y6-Y9 (1-4) were isolated and characterized from the scale-up fermentation of the Streptomyces sp. strain Gö-GS12, as well as actinomycin Zp (5), which was, for the first time, isolated as a natural product. Structures of the new compounds were elucidated by the cumulative analyses of NMR spectroscopy and HRMS. The 4-hydroxythreonine on the β-ring of 1 uniquely undergoes both a rearrangement by a 2-fold acyl shift and an additional ring closure with the amino group of the phenoxazinone chromophore, and the α-rings of 4 and 5 contain a rare 5-methyl proline. Compounds 2-5 showed potent antibacterial activities against Gram-positive bacteria that correlated with cytotoxicity against representative human cell lines. The combination of a β-ring rearrangement and additional ring closure in 1 rendered this actinomycin significantly less potent relative to the nonrearranged comparator actinomycin Y5 and other actinomycins.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27736087      PMCID: PMC5217177          DOI: 10.1021/acs.jnatprod.6b00742

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  11 in total

1.  A new actinomycin-type chromopeptide from Streptomyces sp. HKI-0155.

Authors:  H Lackner; H Hülsmann; S Heinze; H Simon; H Bär; C Zimmer; U Gräfe
Journal:  J Antibiot (Tokyo)       Date:  2000-01       Impact factor: 2.649

2.  Clinical studies on actinomycin D with special reference to Wilms' tumor in children.

Authors:  S FARBER; G D'ANGIO; A EVANS; A MITUS
Journal:  Ann N Y Acad Sci       Date:  1960-10-05       Impact factor: 5.691

3.  Actinomycins with altered threonine units in the beta-peptidolactone.

Authors:  Jens Bitzer; Victoria Gesheva; Axel Zeeck
Journal:  J Nat Prod       Date:  2006-08       Impact factor: 4.050

4.  The treatment of Wilms' tumor: results of the Second National Wilms' Tumor Study.

Authors:  G J D'Angio; A Evans; N Breslow; B Beckwith; H Bishop; V Farewell; W Goodwin; L Leape; N Palmer; L Sinks; W Sutow; M Tefft; J Wolff
Journal:  Cancer       Date:  1981-05-01       Impact factor: 6.860

5.  Structures of five components of the actinomycin Z complex from Streptomyces fradiae, two of which contain 4-chlorothreonine.

Authors:  H Lackner; I Bahner; N Shigematsu; L K Pannell; A B Mauger
Journal:  J Nat Prod       Date:  2000-03       Impact factor: 4.050

6.  Structural, physical, and biological characteristics of RNA.DNA binding agent N8-actinomycin D.

Authors:  M Shinomiya; W Chu; R G Carlson; R F Weaver; F Takusagawa
Journal:  Biochemistry       Date:  1995-07-04       Impact factor: 3.162

7.  Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances.

Authors:  Irith Wiegand; Kai Hilpert; Robert E W Hancock
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

8.  Protactin, a new antibiotic metabolite and a possible precursor of the actinomycins.

Authors:  M Hanada; K Sugawara; Y Nishiyama; H Kamei; M Hatori; M Konishi
Journal:  J Antibiot (Tokyo)       Date:  1992-01       Impact factor: 2.649

9.  First Y-type actinomycins from Streptomyces with divergent structure-activity relationships for antibacterial and cytotoxic properties.

Authors:  Jens Bitzer; Martin Streibel; Hans-Jörg Langer; Stephanie Grond
Journal:  Org Biomol Chem       Date:  2008-12-11       Impact factor: 3.876

10.  Mullinamides A and B, new cyclopeptides produced by the Ruth Mullins coal mine fire isolate Streptomyces sp. RM-27-46.

Authors:  Xiachang Wang; Khaled A Shaaban; Sherif I Elshahawi; Larissa V Ponomareva; Manjula Sunkara; Gregory C Copley; James C Hower; Andrew J Morris; Madan K Kharel; Jon S Thorson
Journal:  J Antibiot (Tokyo)       Date:  2014-04-09       Impact factor: 2.649

View more
  8 in total

1.  Self-Resistance during Muraymycin Biosynthesis: a Complementary Nucleotidyltransferase and Phosphotransferase with Identical Modification Sites and Distinct Temporal Order.

Authors:  Zheng Cui; Xia-Chang Wang; Xiaodong Liu; Anke Lemke; Stefan Koppermann; Christian Ducho; Jürgen Rohr; Jon S Thorson; Steven G Van Lanen
Journal:  Antimicrob Agents Chemother       Date:  2018-06-26       Impact factor: 5.191

Review 2.  Antibacterial natural products from microbial and fungal sources: a decade of advances.

Authors:  Sangeetha Mohan; M S Ajay Krishna; Manasa Chandramouli; Rangappa S Keri; Siddappa A Patil; Srikantamurthy Ningaiah; Sasidhar B Somappa
Journal:  Mol Divers       Date:  2022-03-17       Impact factor: 2.943

3.  Antibacterial Muraymycins from Mutant Strains of Streptomyces sp. NRRL 30471.

Authors:  Zheng Cui; Xiachang Wang; Stefan Koppermann; Jon S Thorson; Christian Ducho; Steven G Van Lanen
Journal:  J Nat Prod       Date:  2018-03-19       Impact factor: 4.050

4.  Neo-actinomycins A and B, natural actinomycins bearing the 5H-oxazolo[4,5-b]phenoxazine chromophore, from the marine-derived Streptomyces sp. IMB094.

Authors:  Qiang Wang; Yixuan Zhang; Mian Wang; Yi Tan; Xinxin Hu; Hongwei He; Chunling Xiao; Xuefu You; Yiguang Wang; Maoluo Gan
Journal:  Sci Rep       Date:  2017-06-15       Impact factor: 4.379

5.  Identification, Bioactivity, and Productivity of Actinomycins from the Marine-Derived Streptomyces heliomycini.

Authors:  Dongyang Wang; Cong Wang; Pengyan Gui; Haishan Liu; Sameh M H Khalaf; Elsayed A Elsayed; Mohammed A M Wadaan; Wael N Hozzein; Weiming Zhu
Journal:  Front Microbiol       Date:  2017-06-28       Impact factor: 5.640

6.  Actinomycin V Suppresses Human Non-Small-Cell Lung Carcinoma A549 Cells by Inducing G2/M Phase Arrest and Apoptosis via the p53-Dependent Pathway.

Authors:  Shi-Qi Lin; Fu-Juan Jia; Cai-Yun Zhang; Fang-Yuan Liu; Jia-Hui Ma; Zhuo Han; Wei-Dong Xie; Xia Li
Journal:  Mar Drugs       Date:  2019-10-09       Impact factor: 5.118

7.  Isolation, characterization, anti-MRSA evaluation, and in-silico multi-target anti-microbial validations of actinomycin X2 and actinomycin D produced by novel Streptomyces smyrnaeus UKAQ_23.

Authors:  Kamal A Qureshi; Avinash D Bholay; Pankaj K Rai; Hamdoon A Mohammed; Riaz A Khan; Faizul Azam; Mariusz Jaremko; Abdul-Hamid Emwas; Piotr Stefanowicz; Mateusz Waliczek; Monika Kijewska; Ehab A Ragab; Medhat Rehan; Gamal O Elhassan; Md Jamir Anwar; Dinesh K Prajapati
Journal:  Sci Rep       Date:  2021-07-15       Impact factor: 4.379

8.  Streptomyces nigra sp. nov. Is a Novel Actinobacterium Isolated From Mangrove Soil and Exerts a Potent Antitumor Activity in Vitro.

Authors:  Can Chen; Yanghui Ye; Ruijun Wang; Yinglao Zhang; Chen Wu; Sanjit C Debnath; Zhongjun Ma; Jidong Wang; Min Wu
Journal:  Front Microbiol       Date:  2018-07-18       Impact factor: 5.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.